The Role of Photoactivated and Non-Photoactivated Verteporfin on Tumor
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Role of Photoactivated and Non-Photoactivated Verteporfin on Tumor
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-10-15
DOI
10.3389/fphar.2020.557429
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Zinc finger protein 367 promotes metastasis by inhibiting the Hippo pathway in breast cancer
- (2020) Xianqiu Wu et al. ONCOGENE
- Photodynamic Therapy in Primary Breast Cancer
- (2020) Shramana M. Banerjee et al. Journal of Clinical Medicine
- Heat shock protein 90-targeted photodynamic therapy enables treatment of subcutaneous and visceral tumors
- (2020) Kensuke Kaneko et al. Communications Biology
- Anti-proliferative and anti-migratory effects of a novel YAP-TEAD interaction inhibitor identified using in silico molecular docking
- (2019) Sarah Smith et al. JOURNAL OF MEDICINAL CHEMISTRY
- Targeted and Synergic Glioblastoma Treatment: Multifunctional Nanoparticles Delivering Verteporfin as Adjuvant Therapy for Temozolomide Chemotherapy
- (2019) Diogo S. Pellosi et al. MOLECULAR PHARMACEUTICS
- Requirement for YAP1 signaling in myxoid liposarcoma
- (2019) Marcel Trautmann et al. EMBO Molecular Medicine
- SS18-SSX-dependent YAP/TAZ Signaling in Synovial Sarcoma
- (2019) Ilka Isfort et al. CLINICAL CANCER RESEARCH
- Core-matched nanoassemblies for targeted co-delivery of chemotherapy and photosensitizer to treat drug-resistant cancer
- (2019) Di Jiang et al. Acta Biomaterialia
- A brief review: some compounds targeting YAP against malignancies
- (2019) Zhenxue Tang et al. Future Oncology
- Aberrant activation of CYR61 enhancers in colorectal cancer development
- (2019) Lingzhu Xie et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Targeting Cancer Stem Cells: A Strategy for Effective Eradication of Cancer
- (2019) Masahiro Shibata et al. Cancers
- YAP promotes multi-drug resistance and inhibits autophagy-related cell death in hepatocellular carcinoma via the RAC1-ROS-mTOR pathway
- (2019) Yuan Zhou et al. Cancer Cell International
- On the relationship of YAP and FAK in hMSCs and osteosarcoma cells: Discrimination of FAK modulation by nuclear YAP depletion or YAP silencing
- (2019) Ayman Husari et al. CELLULAR SIGNALLING
- YAP promotes the malignancy of endometrial cancer cells via regulation of IL-6 and IL-11
- (2019) Jing Wang et al. MOLECULAR MEDICINE
- Central serous chorioretinopathy: Towards an evidence-based treatment guideline
- (2019) Thomas J. van Rijssen et al. PROGRESS IN RETINAL AND EYE RESEARCH
- Verteporfin targeting YAP1/TAZ‐TEAD transcriptional activity inhibits the tumorigenic properties of gastric cancer stem cells
- (2019) Julie Giraud et al. INTERNATIONAL JOURNAL OF CANCER
- Nanoemulsion Structural Design in Co-Encapsulation of Hybrid Multifunctional Agents: Influence of the Smart PLGA Polymers on the Nanosystem-Enhanced Delivery and Electro-Photodynamic Treatment
- (2019) Urszula Bazylińska et al. Pharmaceutics
- Verteporfin-induced lysosomal compartment dysregulation potentiates the effect of sorafenib in hepatocellular carcinoma
- (2019) Jacopo Gavini et al. Cell Death & Disease
- Identification of Celastrol as a Novel YAP-TEAD Inhibitor for Cancer Therapy by High Throughput Screening with Ultrasensitive YAP/TAZ–TEAD Biosensors
- (2019) Kazem Nouri et al. Cancers
- Verteporfin-Loaded Lipid Nanoparticles Improve Ovarian Cancer Photodynamic Therapy In Vitro and In Vivo
- (2019) Michy et al. Cancers
- Fluorescence polarization assay for the identification and evaluation of inhibitors at YAP–TEAD protein–protein interface 3
- (2019) Wei Zhou et al. ANALYTICAL BIOCHEMISTRY
- Verteporfin inhibits oxidative phosphorylation and induces cell death specifically in glioma stem cells
- (2019) Kenta Kuramoto et al. FEBS Journal
- The role of liposomes in clinical nanomedicine development. What now? Now what?
- (2019) Daan J.A. Crommelin et al. JOURNAL OF CONTROLLED RELEASE
- ROCK2 deprivation leads to the inhibition of tumor growth and metastatic potential in osteosarcoma cells through the modulation of YAP activity
- (2019) Cinzia Zucchini et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Structural and ligand-binding analysis of the YAP-binding domain of transcription factor TEAD4
- (2018) Yan Li et al. BIOCHEMICAL JOURNAL
- Photodynamic therapy – mechanisms, photosensitizers and combinations
- (2018) Stanisław Kwiatkowski et al. BIOMEDICINE & PHARMACOTHERAPY
- Photodynamic therapy for choroidal carcinoid metastasis
- (2018) Chia-Kai Chu et al. CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE
- The Photosensitizing Clinical Agent Verteporfin is an Inhibitor of SPAK and OSR1 Kinases
- (2018) Mubarak A AlAmri et al. CHEMBIOCHEM
- S1P Stimulates Proliferation by Up-regulating CTGF Expression through S1PR2-mediated YAP Activation
- (2018) Jung-Chien Cheng et al. MOLECULAR CANCER RESEARCH
- Doxycycline modulates VEGF-A expression: Failure of doxycycline-inducible lentivirus shRNA vector to knockdown VEGF-A expression in transgenic mice
- (2018) Mari Merentie et al. PLoS One
- p62 as a therapeutic target for inhibition of autophagy in prostate cancer
- (2018) Lei Wang et al. PROSTATE
- PHOTODYNAMIC THERAPY AS PRIMARY TREATMENT FOR SMALL CHOROIDAL MELANOMA
- (2018) Elif B. Turkoglu et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- miR-375 is involved in Hippo pathway by targeting YAP1/TEAD4-CTGF axis in gastric carcinogenesis
- (2018) Wei Kang et al. Cell Death & Disease
- A low microRNA-630 expression confers resistance to tyrosine kinase inhibitors in EGFR-mutated lung adenocarcinomas via miR-630/YAP1/ERK feedback loop
- (2018) De-Wei Wu et al. Theranostics
- Toward the Discovery of a Novel Class of YAP–TEAD Interaction Inhibitors by Virtual Screening Approach Targeting YAP–TEAD Protein–Protein Interface
- (2018) Floriane Gibault et al. Cancers
- Long noncoding RNA NSCLCAT1 increases non–small cell lung cancer cell invasion and migration through the Hippo signaling pathway by interacting with CDH1
- (2018) Wei Zhao et al. FASEB JOURNAL
- EGF Receptor–Dependent YAP Activation Is Important for Renal Recovery from AKI
- (2018) Jianchun Chen et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Contact inhibition controls cell survival and proliferation via YAP/TAZ-autophagy axis
- (2018) Mariana Pavel et al. Nature Communications
- Verteporfin selectively kills hypoxic glioma cells through iron-binding and increased production of reactive oxygen species
- (2018) Katherine L. Eales et al. Scientific Reports
- Role of inhibitor of yes-associated protein 1 in triple-negative breast cancer with taxol-based chemoresistance
- (2018) Ying Li et al. CANCER SCIENCE
- Helicobacter pylori CagA promotes epithelial mesenchymal transition in gastric carcinogenesis via triggering oncogenic YAP pathway
- (2018) Nianshuang Li et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Co-Administered Polymeric Nano-Antidotes for Improved Photo-Triggered Response in Glioblastoma
- (2018) Janel Kydd et al. Pharmaceutics
- Induction of Chromosome Instability by Activation of Yes-Associated Protein and Forkhead Box M1 in Liver Cancer
- (2017) Sofia M.E. Weiler et al. GASTROENTEROLOGY
- Targeting YAP in malignant pleural mesothelioma
- (2017) Wen-Qian Zhang et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Nestin expression is dynamically regulated in cardiomyocytes during embryogenesis
- (2017) Vanessa Hertig et al. JOURNAL OF CELLULAR PHYSIOLOGY
- YAP transcriptionally regulates COX-2 expression and GCCSysm-4 (G-4), a dual YAP/COX-2 inhibitor, overcomes drug resistance in colorectal cancer
- (2017) Wei Li et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Targeting Transcriptional Enhanced Associate Domains (TEADs)
- (2017) Floriane Gibault et al. JOURNAL OF MEDICINAL CHEMISTRY
- Verteporfin based silica nanoparticle for in vitro selective inhibition of human highly invasive melanoma cell proliferation
- (2017) Manuela Rizzi et al. JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY
- Targeting Phosphatidylinositol 3-Kinase Signaling Pathway for Therapeutic Enhancement of Vascular-Targeted Photodynamic Therapy
- (2017) Daniel Kraus et al. MOLECULAR CANCER THERAPEUTICS
- Mechanobiology of YAP and TAZ in physiology and disease
- (2017) Tito Panciera et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Targeting YAP/TAZ-TEAD protein-protein interactions using fragment-based and computational modeling approaches
- (2017) Hung Yi Kristal Kaan et al. PLoS One
- Regulation of the Hippo Pathway Transcription Factor TEAD
- (2017) Kimberly C. Lin et al. TRENDS IN BIOCHEMICAL SCIENCES
- Photodynamic-Immune Checkpoint Therapy Eradicates Local and Distant Tumors by CD8 + T Cells
- (2017) Jan Willem Kleinovink et al. Cancer Immunology Research
- Importance of CD200 expression by tumor or host cells to regulation of immunotherapy in a mouse breast cancer model
- (2017) Anna Curry et al. PLoS One
- Verteporfin-induced formation of protein cross-linked oligomers and high molecular weight complexes is mediated by light and leads to cell toxicity
- (2017) Eleni K. Konstantinou et al. Scientific Reports
- Verteporfin inhibits growth of human glioma in vitro without light activation
- (2017) Ahmad Al-Moujahed et al. Scientific Reports
- New photosensitizers for photodynamic therapy
- (2016) H. Abrahamse et al. BIOCHEMICAL JOURNAL
- WW domain binding protein 5 induces multidrug resistance of small cell lung cancer under the regulation of miR-335 through the Hippo pathway
- (2016) Ruixiang Tang et al. BRITISH JOURNAL OF CANCER
- Verteporfin can Reverse the Paclitaxel Resistance Induced by YAP Over-Expression in HCT-8/T Cells without Photoactivation through Inhibiting YAP Expression
- (2016) Wang Pan et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Non-Photoinduced Biological Properties of Verteporfin
- (2016) Floriane Gibault et al. CURRENT MEDICINAL CHEMISTRY
- Photodynamic therapy: current role in the treatment of chorioretinal conditions
- (2016) D K Newman EYE
- Mechanisms of Hippo pathway regulation
- (2016) Zhipeng Meng et al. GENES & DEVELOPMENT
- Pluronic® P123/F127 mixed micelles delivering sorafenib and its combination with verteporfin in cancer cells
- (2016) Salvatore Sortino et al. International Journal of Nanomedicine
- XPO1-dependent nuclear export is a druggable vulnerability in KRAS-mutant lung cancer
- (2016) Jimi Kim et al. NATURE
- The Hippo Pathway and YAP/TAZ–TEAD Protein–Protein Interaction as Targets for Regenerative Medicine and Cancer Treatment
- (2015) Matteo Santucci et al. JOURNAL OF MEDICINAL CHEMISTRY
- Microenvironment rigidity modulates responses to the HER2 receptor tyrosine kinase inhibitor lapatinib via YAP and TAZ transcription factors
- (2015) Chun-Han Lin et al. MOLECULAR BIOLOGY OF THE CELL
- YAP induces high-grade serous carcinoma in fallopian tube secretory epithelial cells
- (2015) G Hua et al. ONCOGENE
- Verteporfin Photodynamic Therapy for the Treatment of Retinal Vasoproliferative Tumors
- (2015) Rumana N. Hussain et al. OPHTHALMOLOGY
- NF2 Loss Promotes Oncogenic RAS-Induced Thyroid Cancers via YAP-Dependent Transactivation of RAS Proteins and Sensitizes Them to MEK Inhibition
- (2015) M. E. R. Garcia-Rendueles et al. Cancer Discovery
- Phase I/II study of verteporfin photodynamic therapy in locally advanced pancreatic cancer
- (2014) M T Huggett et al. BRITISH JOURNAL OF CANCER
- Treatment of posterior uveal melanoma with multi-dose photodynamic therapy
- (2014) Paul Rundle BRITISH JOURNAL OF OPHTHALMOLOGY
- Mutant Gq/11 Promote Uveal Melanoma Tumorigenesis by Activating YAP
- (2014) Fa-Xing Yu et al. CANCER CELL
- Induction of Covalently Crosslinked p62 Oligomers with Reduced Binding to Polyubiquitinated Proteins by the Autophagy Inhibitor Verteporfin
- (2014) Elizabeth Donohue et al. PLoS One
- The Autophagy Inhibitor Verteporfin Moderately Enhances the Antitumor Activity of Gemcitabine in a Pancreatic Ductal Adenocarcinoma Model
- (2013) Elizabeth Donohue et al. Journal of Cancer
- Evaluation of verteporfin pharmakokinetics – redefining the need of photosensitizers in ophthalmology
- (2012) Focke Ziemssen et al. Expert Opinion on Drug Metabolism & Toxicology
- Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP
- (2012) Y. Liu-Chittenden et al. GENES & DEVELOPMENT
- CLINICAL AND HISTOPATHOLOGIC FINDINGS AFTER PHOTODYNAMIC THERAPY OF CHOROIDAL MELANOMA
- (2012) Irene Canal-Fontcuberta et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Akt-Mediated Regulation of Autophagy and Tumorigenesis Through Beclin 1 Phosphorylation
- (2012) R. C. Wang et al. SCIENCE
- The Hippo-YAP pathway in organ size control and tumorigenesis: an updated version
- (2010) B. Zhao et al. GENES & DEVELOPMENT
- Inhibition of Autophagosome Formation by the Benzoporphyrin Derivative Verteporfin
- (2010) Elizabeth Donohue et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Permanent Occlusion of Feeding Arteries and Draining Veins in Solid Mouse Tumors by Vascular Targeted Photodynamic Therapy (VTP) with Tookad
- (2010) Noa Madar-Balakirski et al. PLoS One
- Disparity between prostate tumor interior versus peripheral vasculature in response to verteporfin-mediated vascular-targeting therapy
- (2008) Bin Chen et al. INTERNATIONAL JOURNAL OF CANCER
- Intravital high-resolution optical imaging of individual vessel response to photodynamic treatment
- (2008) Mamta Khurana et al. JOURNAL OF BIOMEDICAL OPTICS
- Intravital Microscopic Analysis of Vascular Perfusion and Macromolecule Extravasation after Photodynamic Vascular Targeting Therapy
- (2008) Chong He et al. PHARMACEUTICAL RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started